Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,627 total articles

WISeKey Announces Results of Class B Share Election and Name Change of BVI Merger Subsidiary to WISeQey Corp.

WISeKey Announces Results of Class B Share Election and Name Change of BVI Merger Subsidiary to WISeQey Corp.

WISeKey International Holding Ltd announced the results of its Class B share election process linked to its planned cross-border merger into its British Virgin Islands subsidiary renamed WISeQey Corp. The merger, approved by shareholders, is pending final regulatory and administrative approvals, after which WISeQey ordinary shares are expected to c…

NOMAD Power Solutions Expands Its Canadian Commercial Presence with Appointment of Global Environmental Liquid Ltd. as Sales Representative

NOMAD Power Solutions Expands Its Canadian Commercial Presence with Appointment of Global Environmental Liquid Ltd. as Sales Representative

NOMAD Power Solutions, a US-based provider of transportable utility-grade battery energy storage systems, has appointed Global Environmental Liquid Ltd. (GEL) as its sales representative in Canada. This partnership aims to leverage GEL's established relationships in Canadian mining, utility, and industrial sectors to drive adoption of NOMAD's rapid…

Runway Growth Finance Corp. Prices Offering of 7.75% Notes due 2031

Runway Growth Finance Corp. Prices Offering of 7.75% Notes due 2031

Runway Growth Finance Corp. announced an underwritten public offering of $45 million aggregate principal amount of notes due 2031, bearing interest at 7.75%, with net proceeds intended for repayment of existing high-interest debt and general corporate purposes. The company aims to redeem its outstanding 9% Senior Notes due 2027, optimize its capita…

Star Fashion Culture Holdings Limited Announces Pricing of Approximately US$9,600,000 Million Public Offering of Class A Ordinary Shares

Star Fashion Culture Holdings Limited Announces Pricing of Approximately US$9,600,000 Million Public Offering of Class A Ordinary Shares

Star Fashion Culture Holdings Limited (NASDAQ: STFS) announced the pricing of a best-efforts follow-on public offering of 12 million Class A ordinary shares at $0.80 per share, aiming to raise approximately $9.6 million gross proceeds. The company plans to use the net proceeds for developing online marketing services as well as for general administ…

Teladoc Health Announces Chief Legal Officer Transition

Teladoc Health Announces Chief Legal Officer Transition

Teladoc Health announced a leadership transition in its legal department with Jonathan Dorfman named as the new Chief Legal Officer and Secretary effective November 2, 2026, succeeding Adam Vandervoort who is resigning after 11 years. Dorfman has been with Teladoc since 2020 and brings extensive legal and corporate governance expertise to the role,…

Astrotech Reports Fiscal Year 2026 Financial Results

Astrotech Reports Fiscal Year 2026 Financial Results

Astrotech Corporation announced its financial results for the fiscal year ending June 30, 2026. The company reported a net loss of $14.4 million, a slight increase compared to the previous year, with revenues of $913,000. Operating expenses declined by 6% to $14 million. Astrotech expanded deployment of its TRACER 1000 technology globally and launc…

Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure

Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure

Adaptive Biotechnologies highlights the new international consensus definition of cure for multiple myeloma, which places highly sensitive measurable residual disease (MRD) negativity at its core, as announced at the International Myeloma Society meeting. The definition requires sustained MRD negativity assessed by next-generation sequencing or flo…

Alpha Compute Regains Full Compliance with Nasdaq Listing Rules

Alpha Compute Regains Full Compliance with Nasdaq Listing Rules

Alpha Compute Corp., a provider of AI compute infrastructure and GPU services, announced it has regained compliance with Nasdaq Listing Rules by meeting the minimum closing bid price requirement of $1.00 per share. This marks the resolution of the prior deficiency noted in March 2026 and reflects ongoing efforts to strengthen the company and delive…

NANO Nuclear, IP3 and Cybernetic Intelligence Sign Letter of Intent to Pursue Nuclear-Powered AI Infrastructure Projects

NANO Nuclear, IP3 and Cybernetic Intelligence Sign Letter of Intent to Pursue Nuclear-Powered AI Infrastructure Projects

NANO Nuclear Energy Inc., alongside IP3 Corporation and Cybernetic Intelligence, signed a Letter of Intent to jointly explore nuclear-powered artificial intelligence and critical infrastructure projects in the U.S. and select international markets. The collaboration names NANO Nuclear as the preferred nuclear technology provider, combining expertis…

Navient names Diane Offereins as new board member

Navient names Diane Offereins as new board member

Navient has appointed Diane Offereins, a seasoned executive with over 35 years in financial services and expertise in executive compensation, IT, and cybersecurity, to its board of directors effective September 24, 2026. This strategic addition follows the retirement of a board member earlier in June 2026 and is expected to enhance the company’s le…

Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate  Robert J. O'Neill to Advisory Board

Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board

Nutriband Inc., a US-based biotech company developing abuse-deterrent transdermal pharmaceutical products, has appointed Robert J. O'Neill, a highly decorated former Navy SEAL and veterans health advocate, to its Advisory Board. O'Neill's extensive leadership experience and advocacy for veterans' health align with Nutriband's mission as the company…

Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD

Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD

Firefly Neuroscience (NASDAQ: AIFF) announced a strategic partnership with NeuroSigma to broaden clinician access to NeuroSigma’s Monarch eTNS® System, the first FDA-cleared non-drug treatment for pediatric ADHD. The partnership integrates Firefly’s AI-powered Evoke™ brain assessment platform with Monarch’s at-home external trigeminal nerve stimula…

Quantum Cyber Sharpens Strategic Focus to Quantum Navigation, Interceptor Drones, and U.S. Manufacturing, and Presents New Corporate Investor Presentation

Quantum Cyber Sharpens Strategic Focus to Quantum Navigation, Interceptor Drones, and U.S. Manufacturing, and Presents New Corporate Investor Presentation

Quantum Cyber N.V. announced a strategic repositioning emphasizing its AI-powered quantum antenna technology and autonomous drones designed for GPS-denied warfare environments. The company is narrowing its focus to three core product pillars and accelerating U.S.-based manufacturing with a new facility in Connecticut, complemented by favorable U.S.…

X-energy Announces Planned Retirement of TRISO-X President Joel Duling

X-energy Announces Planned Retirement of TRISO-X President Joel Duling

X-energy announced the planned retirement of Joel Duling as president of TRISO-X, its nuclear fuels subsidiary, effective November 20, 2026. Duling will transition to a senior advisory role while interim leadership takes over and the company searches for a permanent successor. The firm continues to progress on the construction of the TX-1 advanced …

Cerenome to Hold CNSide® Business Update Call on September 30, 2026

Cerenome to Hold CNSide® Business Update Call on September 30, 2026

Cerenome, Inc., a CNS oncology company, announced a conference call on September 30, 2026, to provide updates on its CNSide® cerebrospinal fluid diagnostic platform. The update will highlight recent progress in commercial activities including third-party billing, market access, expansion of the commercial team, and testing portfolio growth. Cerenom…

Edible Garden Wins Third New Walmart Fresh Herb Distribution Center Award, Accelerating Expansion Across the Eastern Midwest

Edible Garden Wins Third New Walmart Fresh Herb Distribution Center Award, Accelerating Expansion Across the Eastern Midwest

Edible Garden AG Incorporated announced it has secured a third Walmart distribution center for its fresh herb products, expanding its presence across the Eastern Midwest. This award enhances its regional retail reach, improves supply chain efficiency, and supports growth into higher-margin food and nutrition products. The company continues to lever…

Ocugen Receives Provisional Approval and Priority Designation Under the Longevity and Regenerative Therapies Act in The Bahamas to Provide OCU400 to Patients for Treatment of Retinitis Pigmentosa

Ocugen Receives Provisional Approval and Priority Designation Under the Longevity and Regenerative Therapies Act in The Bahamas to Provide OCU400 to Patients for Treatment of Retinitis Pigmentosa

Ocugen, Inc. announced that its investigational gene therapy OCU400 has received provisional approval and priority designation from the Longevity and Regenerative Therapies Board in The Bahamas. This approval enables Ocugen to offer OCU400 through an expanded access program with plans to treat the first patient within 90 days post full approval. OC…

Legend Biotech Presents CARVYKTI Data Showing Half of Patients with RRMM Remained Progression-Free and Alive Five Years After a Single Infusion

Legend Biotech Presents CARVYKTI Data Showing Half of Patients with RRMM Remained Progression-Free and Alive Five Years After a Single Infusion

Legend Biotech Corp. reported five-year follow-up results from the CARTITUDE-2 study cohort A demonstrating that 50% of patients with relapsed/refractory multiple myeloma (RRMM) treated with a single infusion of CARVYKTI (ciltacabtagene autoleucel) remain alive and progression-free without maintenance therapy. The data reinforce the potential curat…

Reborn Coffee Enters into Strategic MOU with Visvita to Expand Global Franchise Supply Chain and Enter RTD Beverage Channels

Reborn Coffee Enters into Strategic MOU with Visvita to Expand Global Franchise Supply Chain and Enter RTD Beverage Channels

Reborn Coffee, Inc. has signed a non-binding Memorandum of Understanding with Visvita, a beverage and distribution company, to leverage Visvita’s US and Mexico distribution infrastructure for expanding Reborn's global franchise supply chain and launching a co-branded ready-to-drink (RTD) beverage lineup. The partnership aims to improve supply chain…

Fate Therapeutics Announces Receipt of California Institute for Regenerative Medicine (CIRM) CLIN2 Grant to Advance RECLAIM-LN

Fate Therapeutics Announces Receipt of California Institute for Regenerative Medicine (CIRM) CLIN2 Grant to Advance RECLAIM-LN

Fate Therapeutics announced a $15 million grant award from the California Institute for Regenerative Medicine (CIRM) to support its Phase 2 RECLAIM-LN trial, investigating FT819, an off-the-shelf CAR T-cell therapy for patients with refractory moderate-to-severe lupus nephritis. The therapy aims to offer durable B cell depletion, potentially improv…

FactSet Appoints Marcel Prins to Board of Directors

FactSet Appoints Marcel Prins to Board of Directors

FactSet has appointed Marcel Prins, an experienced leader in operations, technology, and asset management, to its Board of Directors. Prins's background in digital transformation and data governance at major European asset managers is expected to enhance FactSet's strategic initiatives in AI and financial intelligence solutions.